ELI LILLY & Co — Director's Dealing 2020

Mar 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2020-03-01

Reporting Person: Hakim Anat (Senior VP & General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-01	Restricted Stock Unit	$	A	15857	Acquired		Common Stock (15857.0)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

F2: The Restricted Stock Units vest in two installments, 7,928 on March 1, 2021 and 7,929 on March 1, 2022.